1. Preliminary Report to the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood. Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (BCG), intermittent methotrexate and no therapy after a five-month intensive cytotoxic regimen (Concord trial);Br Med J,1971
2. Report to the Council by the Working Party on Leukaemia in Childhood. Medical Research Council Leukaemia TrialUKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia;J Clin Oncol,1986
3. Report to the Council by the Working Party on Leukaemia in Childhood. Improvement in treatment for children with acute lymphoblastic leukaemia;Lancet;The Medical Research Council UKALL Trials,1972
4. Drug dosage and remission duration in childhood lymphocytic leukemia;Pinkel, D.; Hernandez, K.; Borella, L.;Cancer,1971
5. The effect of drug dosage on outcome and infectious complications in the treatment of childhood lymphocytic leukemia;J, Van Eys; iT, Chen; D, Berry;Proceedings of the American Society for Clinical Oncology,1981